SULIMAN SHEHNAAZ
SEC CIK 1713070 · EDGAR
BoughtSold
Most active insiders at TXG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Saxonov Serge | CEO, Dir | — | $6.82M |
| 2 | Taich Adam | CFO | — | $4.84M |
| 3 | STUELPNAGEL JOHN R | Dir | — | $2.39M |
| 4 | Hindson Benjamin J. | See Remarks, Dir | — | $1.46M |
| 5 | SULIMAN SHEHNAAZ | Dir | — | $791.9K |
| 6 | Teichmann Sarah A. | Dir | — | $579.4K |
| 7 | Kosaraju Sridhar | Dir | — | — |
| 8 | MATEO ALAN | Dir | — | — |
| 9 | Popovits Kimberly J | Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-24 16:30 | 2026-09-22 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Dir | S - Sale | $81.19 | -5,723 | 23.8K | -19% | -$464.7K |
| MT | 2026-08-26 16:42 | 2026-08-24 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Dir | S - Sale | $63.65 | -2,207 | 29.5K | -7% | -$140.5K |
| MT | 2026-06-18 16:08 | 2026-06-16 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Dir | S - Sale | $32.63 | -5,723 | 31.7K | -15% | -$186.8K |
| 2026-06-08 19:26 | 2026-06-04 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +8,829 | 37.4K | +31% | $0 | |
| DT | 2026-05-18 18:41 | 2026-05-14 | RARE | Ultragenyx Pharmaceutical Inc. | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +7,751 | 33.7K | +30% | $0 |
| DT | 2026-05-18 18:41 | 2026-05-18 | RARE | Ultragenyx Pharmaceutical Inc. | SULIMAN SHEHNAAZ | Dir | S - Sale | $25.12 | -5,740 | 28.0K | -17% | -$144.2K |
| 2025-06-05 | 2025-06-03 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +15.4K | 28.6K | +116% | $0 | |
| D | 2025-05-19 | 2025-05-15 | RARE | Ultragenyx Pharmaceutical Inc. | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +5,740 | 25.9K | +28% | $0 |
| D | 2024-06-20 | 2024-06-18 | RARE | Ultragenyx Pharmaceutical Inc. | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +5,345 | 20.2K | +36% | $0 |
| 2024-06-13 | 2024-06-11 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +8,649 | 13.3K | +188% | $0 | |
| D | 2023-06-16 | 2023-06-14 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +1,865 | 4,610 | +68% | $0 |
| D | 2023-06-09 | 2023-06-07 | RARE | Ultragenyx Pharmaceutical Inc. | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +3,860 | 14.9K | +35% | $0 |
| D | 2022-06-28 | 2022-06-24 | RARE | Ultragenyx Pharmaceutical Inc. | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +3,300 | 11.0K | +43% | $0 |
| D | 2022-06-17 | 2022-06-15 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +2,120 | 2,745 | +339% | $0 |
| DM | 2021-12-14 | 2021-12-10+ | ALEC | Alector, Inc. | SULIMAN SHEHNAAZ | Pres, COO | S - Sale+OE | $21.50 | -150.0K | 102.6K | -59% | -$3.23M |
| DM | 2021-12-14 | 2021-12-10+ | ALEC | Alector, Inc. | SULIMAN SHEHNAAZ | Pres, COO | M - OptEx | $17.23 | +150.0K | 177.6K | +544% | +$2.58M |
| DM | 2021-12-10 | 2021-12-08+ | ALEC | Alector, Inc. | SULIMAN SHEHNAAZ | Pres, COO | S - Sale+OE | $22.81 | -150.0K | 141.1K | -52% | -$3.42M |
| DM | 2021-12-10 | 2021-12-08+ | ALEC | Alector, Inc. | SULIMAN SHEHNAAZ | Pres, COO | M - OptEx | $14.66 | +150.0K | 177.6K | +544% | +$2.20M |
Purchase Sale Sale after option exercise All abbreviations